BIOT Stock Overview
Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
BIOT passed our risk checks.
My Notes
Capture your thoughts, links and company narrative
Biotage AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr142.90 |
| 52 Week High | kr226.20 |
| 52 Week Low | kr113.60 |
| Beta | 0.73 |
| 1 Month Change | 12.17% |
| 3 Month Change | -5.80% |
| 1 Year Change | -30.09% |
| 3 Year Change | 1.35% |
| 5 Year Change | 34.05% |
| Change since IPO | 40.10% |
Recent News & Updates
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05Recent updates
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year
Mar 29Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Mar 14Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Feb 13A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jan 23Is Biotage (STO:BIOT) A Risky Investment?
Dec 10Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?
Nov 03Biotage (STO:BIOT) Has A Rock Solid Balance Sheet
Aug 17Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?
Jul 24We Think That There Are More Issues For Biotage (STO:BIOT) Than Just Sluggish Earnings
Apr 01Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Mar 08Is Biotage AB (STO:BIOT) A Great Dividend Stock?
Feb 21Could The Biotage AB (STO:BIOT) Ownership Structure Tell Us Something Useful?
Feb 07
How Much Are Biotage AB (STO:BIOT) Insiders Taking Off The Table?
Jan 14Biotage (STO:BIOT) Has Rewarded Shareholders With An Exceptional 521% Total Return On Their Investment
Dec 28Biotage AB's (STO:BIOT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 10Is Biotage (STO:BIOT) A Risky Investment?
Nov 22How Many Biotage AB (STO:BIOT) Shares Have Insiders Sold, In The Last Year?
Jun 22Shareholder Returns
| BIOT | SE Life Sciences | SE Market | |
|---|---|---|---|
| 7D | -4.0% | -2.1% | -2.1% |
| 1Y | -30.1% | -35.0% | -6.0% |
Return vs Industry: BIOT exceeded the Swedish Life Sciences industry which returned -33.3% over the past year.
Return vs Market: BIOT underperformed the Swedish Market which returned -4.4% over the past year.
Price Volatility
| BIOT volatility | |
|---|---|
| BIOT Average Weekly Movement | 6.4% |
| Life Sciences Industry Average Movement | 7.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 4.0% |
Stable Share Price: BIOT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: BIOT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 516 | Tomas Blomquist | https://www.biotage.com |
Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns.
Biotage AB (publ) Fundamentals Summary
| BIOT fundamental statistics | |
|---|---|
| Market Cap | kr9.43b |
| Earnings (TTM) | kr240.00m |
| Revenue (TTM) | kr1.54b |
39.3x
P/E Ratio6.1x
P/S RatioIs BIOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOT income statement (TTM) | |
|---|---|
| Revenue | kr1.54b |
| Cost of Revenue | kr614.00m |
| Gross Profit | kr927.00m |
| Other Expenses | kr687.00m |
| Earnings | kr240.00m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 17, 2023
| Earnings per share (EPS) | 3.64 |
| Gross Margin | 60.16% |
| Net Profit Margin | 15.57% |
| Debt/Equity Ratio | 9.5% |
How did BIOT perform over the long term?
See historical performance and comparison